NEW YORK, Oct. 2 - To stay attractive to venture capital investors and remain competitive, young genomic companies must have a broad platform that reduces their failure rate, they must be able to generate drug candidates, and they should be more frugal, according to some industry watchers. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.